ATI RN
Drug and Dosage for ET Tube Cardiovascular Pharmacological Agents Questions
Question 1 of 5
When assessing a patient who has been prescribed an antipsychotic medication, which statement would indicate a need for further patient education?
Correct Answer: B
Rationale: The correct answer is B because the statement indicates a potential issue with medication adherence. The patient's lifestyle of constantly moving between Florida and New England may disrupt the medication regimen, leading to missed doses or inconsistent treatment. This lack of adherence can impact the effectiveness of the antipsychotic medication. Choice A is not correct as it indicates a concern about weight loss, which can be a common side effect of antipsychotic medications but does not necessarily indicate a need for further education. Choice C suggests a desire to start a family, which may require additional discussions but is not directly related to medication education. Choice D involves a promise of a reward for stopping the medication, which may indicate a misunderstanding but not necessarily a need for further education.
Question 2 of 5
The nurse is teaching a patient how to self-administer triptan injections for migraine headaches. Which statement by the patient indicates that he needs further teaching?
Correct Answer: A
Rationale: Rationale: Choice A is incorrect because triptan injections are not meant for regular preventive use, but for acute treatment of migraine headaches when they occur. Taking the medication regularly for prevention goes against its intended use and can lead to overuse and potential side effects. Choices B, C, and D are correct as they align with the appropriate use of triptan injections for acute migraine treatment, accurate information about its effects, and monitoring the effectiveness of the treatment, respectively.
Question 3 of 5
The nurse administering the phosphodiesterase inhibitor milrinone (Primacor) recognizes that this drug will have a positive inotropic effect. Which result reflects this effect?
Correct Answer: C
Rationale: Step 1: Milrinone is a phosphodiesterase inhibitor that increases intracellular cAMP levels in cardiac myocytes. Step 2: Increased cAMP levels lead to enhanced calcium influx into cardiac cells, increasing contractility. Step 3: Increased force of cardiac contractions (Choice C) is the direct result of enhanced contractility due to increased cAMP levels. Summary: Choice C is correct since milrinone's mechanism of action directly leads to increased force of cardiac contractions. Choices A, B, and D are incorrect as they do not align with milrinone's mechanism of action and its inotropic effect.
Question 4 of 5
A patient on diuretic therapy calls the clinic because he’s had the flu, with “terrible vomiting and diarrhea,” and he has not kept anything down for 2 days. He feels weak and extremely tired. Which statement by the nurse is correct?
Correct Answer: D
Rationale: The correct answer is D because the patient's symptoms of vomiting, diarrhea, weakness, and extreme tiredness indicate severe dehydration and electrolyte imbalance, which can be dangerous. The nurse should advise the patient to come into the clinic for evaluation to assess his condition, rehydrate him, and check for any complications. This is crucial as the patient may need intravenous fluids and electrolyte replacement therapy. Choice A is incorrect because taking the diuretic with sips of water may not be sufficient to address the dehydration and electrolyte imbalance caused by the flu. Choice B is incorrect because stopping the diuretic abruptly can lead to further electrolyte imbalances and complications. Choice C is incorrect because increasing the dosage of the diuretic without evaluating the patient's condition could worsen the electrolyte imbalance and dehydration.
Question 5 of 5
What does the term “bioavailability” mean?
Correct Answer: C
Rationale: The correct answer is C: Fraction of an uncharged drug reaching the systemic circulation following any route administration. Bioavailability refers to the percentage of an administered drug that reaches the systemic circulation in an unchanged form. This definition excludes options A, B, and D as they do not directly relate to the concept of bioavailability. Plasma protein binding (A) refers to the extent to which a drug binds to proteins in the blood, brain-blood barrier permeability (B) is related to drug penetration into the brain, and the amount of a substance in urine relative to the initial dose (D) is more related to drug excretion rather than bioavailability. Thus, option C is correct as it specifically describes the concept of bioavailability.